NCT05657431

Brief Summary

This study was conducted as a randomized controlled experimental study.To evaluate the effects of aromatherapy, one of the non-pharmacological pain methods, on labor pain and anxiety in the active phase in primiparous pregnant women. The main questions it aims to answer are: Is ylang ylang oil applied as an inhaler effective in reducing labor pain and anxiety? Is lemon oil applied as an inhaler effective in reducing labor pain and anxiety? Participants randomized according to the closed envelope method into the lemon oil group (n=15), ylang ylang oil group (n=15) and control group (n=15). In the active phase (cervical dilatation ≥5), a drop of essential oil was instilled onto square cotton balls to the intervention groups and renewed as one drop every hour until labor occurred. In the control group, 1 drop of saline was dripped onto square cotton balls. Visual pain scale (VAS) and state anxiety ınventory were applied to the intervention groups and control groups before the application. After the application, VAS and state anxiety ınventory were evaluated at 5-7 cm dilatation, and only with VAS at 8-10 cm dilatation. The trait anxiety ınventory was administered to the volunteers after birth.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2019

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2021

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

November 11, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 20, 2022

Completed
Last Updated

December 20, 2022

Status Verified

December 1, 2022

Enrollment Period

2.5 years

First QC Date

November 11, 2022

Last Update Submit

December 10, 2022

Conditions

Keywords

primiparouslabor painaromatherapylemon oilylang ylang oil

Outcome Measures

Primary Outcomes (6)

  • paın score

    Determination of pain score before and after essential oil (lemon oil and ylang ylang oil) and saline inhalation with visual pain score (0=no pain, 10=worst pain)

    pre-intervention

  • paın score

    Determination of pain score before and after essential oil (lemon oil and ylang ylang oil) and saline inhalation with visual pain score (0=no pain, 10=worst pain)

    Between contractions within 1 hour after the intervention in the cervical dilatation range of 5-7 cm

  • paın score

    Determination of pain score before and after essential oil (lemon oil and ylang ylang oil) and saline inhalation with visual pain score (0=no pain, 10=worst pain)

    Between contractions in about 3-4 hours after the intervention in the 8-10 cm cervical dilatation range

  • anxiety level

    Determination of anxiety level before and after essential oil (lemon oil and ylang ylang oil) and saline inhalation with STAI From TX-I and TX-II (State-Trait Anxiety Tests) (The highest possible score is 80 and the lowest possible score is 20)

    pre-intervention

  • anxiety level

    Determination of anxiety level before and after essential oil (lemon oil and ylang ylang oil) and saline inhalation with STAI From TX-I and TX-II (State-Trait Anxiety Tests) (The highest possible score is 80 and the lowest possible score is 20)

    Between contractions within 1 hour after the intervention in the cervical dilatation range of 5-7 cm

  • anxiety level

    Determination of anxiety level before and after essential oil (lemon oil and ylang ylang oil) and saline inhalation with STAI From TX-I and TX-II (State-Trait Anxiety Tests) (The highest possible score is 80 and the lowest possible score is 20)

    postpartum 4-24 hours

Secondary Outcomes (2)

  • apgar score

    postnatal 5. minute

  • apgar score

    postnatal 10. minute

Study Arms (3)

group 1 (Ylang ylang oil)

EXPERIMENTAL

A square cotton ball impregnated with a drop of ylang-ylang oil was placed in the participants randomized to group I (cervical dilatation ≥ 5) with the help of safety pins of pregnant women. One hour after the intervention (in the range of 5-7 cm cervical dilatation), pain levels were measured again with the VAS and anxiety levels were measured with the State Anxiety Scale. The essential oil was renewed as 1 drop every hour until the birth of the baby. When cervical dilatation was in the range of 8-10 cm, pain level was re-evaluated only with VAS. Spielberger Continuity Anxiety Scale was applied with face-to-face interview technique within 4-24 hours following the birth.

Other: essential oils (Ylang ylang oil)

group 2 (Lemon oil)

EXPERIMENTAL

A square cotton ball impregnated with a drop of lemon oil was placed in the participants randomized to group 2 (cervical dilatation ≥ 5) with the help of safety pins of pregnant women. One hour after the intervention (in the range of 5-7 cm cervical dilatation), pain levels were measured again with the VAS and anxiety levels were measured with the State Anxiety Scale. The essential oil was renewed as 1 drop every hour until the birth of the baby. When cervical dilatation was in the range of 8-10 cm, pain level was re-evaluated only with VAS. Spielberger Continuity Anxiety Scale was applied with face-to-face interview technique within 4-24 hours following the birth.

Other: essential oils (lemon oil)

group 3 (Control)

PLACEBO COMPARATOR

A square cotton ball impregnated with a drop of salin was placed in the participants randomized to group I (cervical dilatation ≥ 5) with the help of safety pins of pregnant women. One hour after the intervention (in the range of 5-7 cm cervical dilatation), pain levels were measured again with the VAS and anxiety levels were measured with the State Anxiety Scale. The essential oil was renewed as 1 drop every hour until the birth of the baby. When cervical dilatation was in the range of 8-10 cm, pain level was re-evaluated only with VAS. Spielberger Continuity Anxiety Scale was applied with face-to-face interview technique within 4-24 hours following the birth.

Other: placebo (saline solutions)

Interventions

inhaler aromatherapy

group 1 (Ylang ylang oil)

placebo saline solutions

group 3 (Control)

inhaler aromatherapy

group 2 (Lemon oil)

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailsprengnancy woman
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Term pregnancy (37-41 weeks)
  • Pregnant women between the ages of 18-35
  • had singleton pregnancy with cephalic presentation of the fetus
  • Not allergic to ylang ylang oil, flower/lemon or oil or anything
  • Absence of any pregnancy complications
  • No previous miscarriage, no abortion
  • Not having any diagnosed systemic disease
  • ≥ 5 cm (cm) (active phase) cervical dilatation
  • Pregnant women who do not take any analgesia, anesthesia or anxiolytic drugs
  • Spontaneous onset of labor
  • Pregnant women who can speak and write Turkish well
  • Pregnant woman's consent to participate in the study.

You may not qualify if:

  • Emergency cesarean section indication
  • Use of analgesic, anesthetic and anxiolytic drugs by the pregnant woman
  • The pregnant woman's desire to withdraw from the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Etlik Zübeyde Hanim Hospital

Ankara, Turkey (Türkiye)

Location

Related Publications (1)

  • Kaviani M, Maghbool S, Azima S, Tabaei MH. Comparison of the effect of aromatherapy with Jasminum officinale and Salvia officinale on pain severity and labor outcome in nulliparous women. Iran J Nurs Midwifery Res. 2014 Nov;19(6):666-72.

    PMID: 25558267BACKGROUND

MeSH Terms

Conditions

Labor PainAnxiety Disorders

Interventions

Oils, VolatileSodium Chloridelemon oil

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Intervention Hierarchy (Ancestors)

OilsLipidsChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium Compounds

Study Officials

  • ÖZLEM ÇAĞAN, ASSİST.PROF.

    Eskişehir Osmangazi University

    STUDY DIRECTOR
  • SEVGİ KOÇ, PROF. DR.

    ETLİK ZÜBEYDE HANIM GYN DISEASES TRAINING AND RESEARCH HOSPITAL

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
assistant professor

Study Record Dates

First Submitted

November 11, 2022

First Posted

December 20, 2022

Study Start

June 1, 2019

Primary Completion

November 30, 2021

Study Completion

November 30, 2021

Last Updated

December 20, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations